References
- Tenforde MW, Olson SM, Self WH, Talbot HK, Lindsell CJ, Steingrub JS, Shapiro NI, Ginde AA, Douin DJ, Prekker ME, et al. IVY network; HAIVEN Investigators. Effectiveness of Pfizer-BioNTech and moderna vaccines against COVID-19 among hospitalized adults aged ≥65 years — United States, January–March 2021. Morb Mortal Wkly Rep. 2021;70(18):674–79. doi:10.15585/mmwr.mm7018e1.
- Egan C, Knight S, Baillie K, Harrison E, Docherty A, Semple C Hospitalised vaccinated patients during the second wave, update April ‘21. [accessed 2021 May 6]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/982499/S1208_CO-CIN_report_on_impact_of_vaccination_Apr_21.pdf
- Datoo MS, Natama HM, Somé A, Traoré O, Rouamba T, Bellamy D, Yameogo P, Valia D, Tegneri M, Ouedraogo F, et al. High efficacy of a low dose candidate malaria vaccine, R21 in 1 adjuvant matrix-M™, with seasonal administration to children in Burkina Faso. SSRN [Prepr]. 2021. doi:10.2139/ssrn.3830681.